IL182135A0 - Liquid allergy vaccine formulation for ormucosal administration - Google Patents

Liquid allergy vaccine formulation for ormucosal administration

Info

Publication number
IL182135A0
IL182135A0 IL182135A IL18213507A IL182135A0 IL 182135 A0 IL182135 A0 IL 182135A0 IL 182135 A IL182135 A IL 182135A IL 18213507 A IL18213507 A IL 18213507A IL 182135 A0 IL182135 A0 IL 182135A0
Authority
IL
Israel
Prior art keywords
administration
ormucosal
vaccine formulation
allergy vaccine
liquid
Prior art date
Application number
IL182135A
Other languages
English (en)
Original Assignee
Alk Abello As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alk Abello As filed Critical Alk Abello As
Publication of IL182135A0 publication Critical patent/IL182135A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Transplantation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL182135A 2004-09-27 2007-03-22 Liquid allergy vaccine formulation for ormucosal administration IL182135A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61389204P 2004-09-27 2004-09-27
DKPA200401468 2004-09-27
PCT/DK2005/000601 WO2006034707A1 (en) 2004-09-27 2005-09-22 Liquid allergy vaccine formulation for oromucosal administration

Publications (1)

Publication Number Publication Date
IL182135A0 true IL182135A0 (en) 2007-07-24

Family

ID=35431828

Family Applications (1)

Application Number Title Priority Date Filing Date
IL182135A IL182135A0 (en) 2004-09-27 2007-03-22 Liquid allergy vaccine formulation for ormucosal administration

Country Status (16)

Country Link
US (1) US20060115499A1 (enExample)
EP (1) EP1793853B1 (enExample)
JP (1) JP4976298B2 (enExample)
KR (1) KR20070057963A (enExample)
CN (1) CN101048176B (enExample)
AT (1) ATE421330T1 (enExample)
AU (1) AU2005289193A1 (enExample)
CA (1) CA2581815A1 (enExample)
DE (1) DE602005012522D1 (enExample)
DK (1) DK1793853T3 (enExample)
ES (1) ES2321425T3 (enExample)
IL (1) IL182135A0 (enExample)
MX (1) MX2007003609A (enExample)
NO (1) NO20071636L (enExample)
RU (1) RU2007115920A (enExample)
WO (1) WO2006034707A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006310881B2 (en) * 2005-11-04 2012-07-19 Alk-Abello A/S Use of a liquid allergy vaccine formulation for oromucosal administration
ES2370043T3 (es) * 2007-03-28 2011-12-12 Alk-Abelló A/S Uso de una formulación de vacuna de la alergia coadyuvada para administración subcutánea.
DE202008006598U1 (de) 2008-04-11 2008-10-02 Alk-Abelló A/S Allergie-Impfstoff-Formulierung zur mucosalen Verabreichung
CA2739557A1 (en) * 2008-10-15 2010-04-22 Alk-Abello A/S Pharmaceutical product for up-dosing of allergy vaccine
US9545455B2 (en) * 2009-04-29 2017-01-17 Pravin K. Muniyappa Device and method for the diagnosis of gastrointestinal allergy
CN106421775B (zh) * 2015-08-12 2020-12-01 普莱柯生物工程股份有限公司 一种疫苗用佐剂及含该佐剂的疫苗组合物和其应用
BR102017026619A2 (pt) 2017-02-15 2018-10-30 Euroimmun Medizinische Labordiagnostika Ag ensaio melhorado para a diagnose de alergia a amendoim

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3148121A (en) * 1960-01-27 1964-09-08 Miles Lab Water-insoluble whole inhalant complex and method of making same
US3329564A (en) * 1965-06-28 1967-07-04 Parke Davis & Co Antacid preparations and means of producing the same
US4233288A (en) * 1979-03-12 1980-11-11 Cornell John A Gum emulsified liquid package for delivering and preserving liquid content in the mouth
US4341763A (en) * 1981-03-10 1982-07-27 Smithkline-Rit Methods of vaccinating humans against rotavirus infection
JPS61238728A (ja) * 1985-04-16 1986-10-24 Mitsui Norin Kk 茶葉抽出物と活性水酸化アルミニウムとの抗潰瘍性複合体
US6103243A (en) * 1985-05-15 2000-08-15 Biotechnology Australia Pty, Ltd Oral vaccines
KR900701304A (ko) * 1988-05-05 1990-12-01 루이즈 츄이 콜린스 에이미 사람 및/또는 동물용 알레르겐 탈감작제
US5032405A (en) * 1989-09-27 1991-07-16 Warner-Lambert Company Oral pharmaceutical composition for acid sensitive proteinaceous agents
US5443832A (en) * 1990-04-16 1995-08-22 Institut Swisse De Recherches Experimentales Sur Le Cancer Hydroxyapatite-antigen conjugates and methods for generating a poly-Ig immune response
EP0484621A3 (en) * 1990-07-11 1992-08-26 American Cyanamid Company Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens
US5338543A (en) * 1992-02-27 1994-08-16 Ambico, Inc. Thimerosal inactivated mycoplasma hyopneumoniae vaccine
JP3414539B2 (ja) * 1994-05-11 2003-06-09 有限会社ドット 経鼻吸収用組成物
US5985312A (en) * 1996-01-26 1999-11-16 Brown University Research Foundation Methods and compositions for enhancing the bioadhesive properties of polymers
US5985287A (en) * 1996-08-29 1999-11-16 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US20020068090A1 (en) * 1999-02-03 2002-06-06 Bell Steve J. D. Calcium phosphate particles as mucosal adjuvants
CN1338947B (zh) * 1999-02-05 2012-11-14 爱尔开-阿贝优公司 粘膜递送系统
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US20020051794A1 (en) * 2000-08-09 2002-05-02 Alk-Abello A/S Novel parenteral vaccine formulations and uses thereof
GB0020089D0 (en) * 2000-08-15 2000-10-04 Smithkline Beecham Biolog Vaccine Composition
KR100919914B1 (ko) * 2000-11-16 2009-10-06 알크-아벨로 에이/에스 신규한 돌연변이체 알레르겐
WO2003096869A2 (en) * 2002-05-16 2003-11-27 Alk Abelló A/S Recombinant bet. v. 1. allergen mutants, methods and process thereof
MXPA05005528A (es) * 2002-11-26 2006-04-05 Alk Abello As Producto farmaceutico de alergeno.

Also Published As

Publication number Publication date
JP2008514557A (ja) 2008-05-08
JP4976298B2 (ja) 2012-07-18
EP1793853B1 (en) 2009-01-21
KR20070057963A (ko) 2007-06-07
US20060115499A1 (en) 2006-06-01
MX2007003609A (es) 2007-06-05
AU2005289193A1 (en) 2006-04-06
ATE421330T1 (de) 2009-02-15
WO2006034707A1 (en) 2006-04-06
HK1106447A1 (en) 2008-03-14
CN101048176A (zh) 2007-10-03
ES2321425T3 (es) 2009-06-05
CN101048176B (zh) 2012-01-11
DK1793853T3 (da) 2009-04-14
NO20071636L (no) 2007-06-14
CA2581815A1 (en) 2006-04-06
RU2007115920A (ru) 2008-11-10
EP1793853A1 (en) 2007-06-13
DE602005012522D1 (de) 2009-03-12

Similar Documents

Publication Publication Date Title
IL182135A0 (en) Liquid allergy vaccine formulation for ormucosal administration
WO2005107726A3 (en) Method for the treatment of back pain
WO2009086112A3 (en) Apparatus and methods for delivering therapeutic agents
EP1676512A3 (en) Skin treatment articles and methods
WO2009074735A3 (fr) Utilisation d'un nouvel agent naturel dans des compositions cosmetiques
WO2006060507A3 (en) Compositions comprising immunomodulatory compounds and the use thereof for the treatment of immunodeficiency disorders
MY162248A (en) Hydrophilic coating
WO2005102338A8 (en) Method of treating neuropathic pain using a crth2 receptor antagonist
TW200621268A (en) Antimicrobial copolymers and uses thereof
UA88463C2 (ru) Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции
ZA200808465B (en) Pharmaceutical formulations:salts of 8-[{1-(3,5-bis (trifluoromethy1)pheny1)-e thoxy}-methy1]-8-pheny1-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same
BRPI0415164A (pt) dispositivo para administrar uma composição bioterapêutica, composição bioterapêutica, método de preparação de uma composição bioterapêutica, método de tratamento, e dispensador
WO2007011955A3 (en) Drug-containing implants and methods of use thereof
EP3305305A3 (en) Silicate containing compositions and methods of treatment
WO2007067519A3 (en) The use of neurotransmitters and neuropeptides for the treatment of dry eye diseases and related conditions
WO2006121522A3 (en) Implantable sensors and pumps, anti-scarring agents, and therapeutic compositions
MX2007003897A (es) Una formulacion farmaceutica que comprende insulina cristalina e insulina disuelta.
PT1713438E (pt) Sabonete medicinal
EP1603595A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DRUG INDEPENDENCE
WO2005105135A8 (en) Il-6 for therapy or prevention of chemotherapy-induced neuropathy
IL182297A (en) Use of winter savory (satureja montana) or the extracts thereof for the preparation of medicaments for the treatment of the premature ejaculation
WO2007084964A3 (en) Pharmaceutical composition comprising a protein pump inhibitor and protein component
PL1874410T3 (pl) Odbarwiająca lub rozjaśniająca kompozycja kosmetyczna zawierająca co najmniej jedną oksazolinę jako składnik aktywny
WO2007077454A3 (en) A therapeutic composition comprising an inhibitor of an hsp 90 protein
DK1759711T3 (da) Chitosan/siliciumdioxid.copræcipitat og anvendelse som excipiens i faste doseringsformer